ACT Lung Health Intervention: Phase Two
Recruiting · NCT06945120 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
ACT Lung Health Intervention
What this trial is about
This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.
Who can take part
Age range
18 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Self-identify as either Chinese or Korean
- Speak either Korean, Mandarin, or English
- Are 18 years of age or older
- Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days)
- Will live in the United States for the next 12 months
Exclusion criteria
- Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.
- We will not include any of the following special populations:
- Adults unable to consent.
- Adults younger than 50 or older than 80 years
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
Where it is running
2 locations listed across 1 US state.
- Dana-Farber Cancer Institute - Boston, Massachusetts, United States
- University of Massachusetts-Boston - Boston, Massachusetts, United States